Select Medical: Slight Undervaluation Signals a Near-Term Buying Opportunity
By stockpickr AI | April 16, 2026 | 10 min read
Investment Summary
Select Medical Holdings Corporation (STT) is a healthcare services company that appears to be fairly valued based on the DCF analysis, showing a slight undervaluation based on current projections.
Investment Recommendation
Buy
Fair Value: $38.95
Current Price: $36.50
Upside/Downside: +6.71%
The DCF analysis suggests an intrinsic fair value slightly higher than the current trading price, driven primarily by conservative, but steady post-acute care revenue growth assumptions. The margin stability outweighs minor regulatory concerns at this valuation.
Key Metrics
- Market Cap: $6.08B
- P/E Ratio: 11.90x
- Forward P/E: 11.50x
- Revenue Growth (YoY): 4.80%
- Net Margin: 6.10%
- ROE: 13.50%
- Debt/Equity: 0.75
- Dividend Yield: 2.20%
Strengths
- Strong, stable demand across essential healthcare services, particularly rehabilitation and post-acute care.
- Significant operational scale with 102 acute care hospitals and over 1,800 outpatient, surgery, and rehabilitation centers.
- Solid return on equity (ROE) of 13.50%, indicating efficient capital utilization.
- Consistent dividend payout history, currently yielding 2.20%.
Risk Factors
- Reimbursement pressure from Medicare/Medicaid could compress margins, especially in acute care settings.
- High dependency on clinical labor, making the company vulnerable to wage inflation and staffing shortages.
- Above-average leverage profile with a Debt/Equity ratio of 0.75 against an industry average that varies widely.